Assessment of caspofungin susceptibility of Candida glabrata by the Etest®, CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutations (Q39251474)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Assessment of caspofungin susceptibility of Candida glabrata by the Etest®, CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutations	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

Assessment of caspofungin susceptibility of Candida glabrata by the Etest®, CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutations (English)

1 reference

Europe PubMed Central

10 September 2017

Candida glabrata

0 references

author name string

N Bourgeois

1

1 reference

Europe PubMed Central

10 September 2017

C Laurens

2

1 reference

Europe PubMed Central

10 September 2017

S Bertout

3

1 reference

Europe PubMed Central

10 September 2017

Y Balard

4

1 reference

Europe PubMed Central

10 September 2017

D Krasteva

5

1 reference

Europe PubMed Central

10 September 2017

P Rispail

6

1 reference

Europe PubMed Central

10 September 2017

L Lachaud

7

1 reference

Europe PubMed Central

10 September 2017

publication date

13 February 2014

1 reference

Europe PubMed Central

10 September 2017

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

10 September 2017

33

1 reference

Europe PubMed Central

10 September 2017

7

1 reference

Europe PubMed Central

10 September 2017

1247-1252

1 reference

Europe PubMed Central

10 September 2017

https://scigraph.springernature.com/pub.10.1007/s10096-014-2069-z

0 references

Caspofungin Etest susceptibility testing of Candida species: risk of misclassification of susceptible isolates of C. glabrata and C. krusei when adopting the revised CLSI caspofungin breakpoints

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

Epidemiology of invasive candidiasis: a persistent public health problem

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

Increases in SLT2 expression and chitin content are associated with incomplete killing of Candida glabrata by caspofungin

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

Novel FKS mutations associated with echinocandin resistance in Candida species

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

Recurrent episodes of candidemia due to Candida glabrata with a mutation in hot spot 1 of the FKS2 gene developed after prolonged therapy with caspofungin

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2069-Z

21 January 2018

Identifiers

10.1007/S10096-014-2069-Z

1 reference

Europe PubMed Central

10 September 2017

1 reference

Europe PubMed Central

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39251474&oldid=1815912185"